WO2004006933A3 - Crystal forms of olanzapine and processes for their preparation - Google Patents

Crystal forms of olanzapine and processes for their preparation Download PDF

Info

Publication number
WO2004006933A3
WO2004006933A3 PCT/SI2003/000024 SI0300024W WO2004006933A3 WO 2004006933 A3 WO2004006933 A3 WO 2004006933A3 SI 0300024 W SI0300024 W SI 0300024W WO 2004006933 A3 WO2004006933 A3 WO 2004006933A3
Authority
WO
WIPO (PCT)
Prior art keywords
olanzapine
preparation
processes
crystal forms
form
Prior art date
Application number
PCT/SI2003/000024
Other languages
French (fr)
Other versions
WO2004006933A2 (en
Inventor
Marija Grcman
Jordan Berta Kotar
Franc Vrecer
Original Assignee
Marija Grcman
Jordan Berta Kotar
Krka D D Novo Mesto
Franc Vrecer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SIP-200200175 priority Critical
Priority to SI200200175A priority patent/SI21270A/en
Application filed by Marija Grcman, Jordan Berta Kotar, Krka D D Novo Mesto, Franc Vrecer filed Critical Marija Grcman
Publication of WO2004006933A2 publication Critical patent/WO2004006933A2/en
Publication of WO2004006933A3 publication Critical patent/WO2004006933A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Abstract

The invention relates to a process for the preparation of form I of olanzapine, crystallized from a solvent mixture which comprises 2-propanol, some pseudopolymorphic forms, namely solvates of olanzapine, a new polymorphic form A of olanzapine, and processes for the preparation thereof.
PCT/SI2003/000024 2002-07-15 2003-07-14 Crystal forms of olanzapine and processes for their preparation WO2004006933A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SIP-200200175 2002-07-15
SI200200175A SI21270A (en) 2002-07-15 2002-07-15 Crystal forms of olanzapine and procedures for their preparation

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
SI200332341T SI1551414T1 (en) 2002-07-15 2003-07-14 Process for preparing the crystal form I of olanzapine
EP03764287.3A EP1551414B1 (en) 2002-07-15 2003-07-14 Process for preparing the crystal form I of olanzapine
YU20050023A RS53474B (en) 2002-07-15 2003-07-14 Processes for preparing the crystal form i of olanzapine
US10/521,646 US7745429B2 (en) 2002-07-15 2003-07-14 Crystal forms of olanzapine and processes for their preparation
CA 2493370 CA2493370C (en) 2002-07-15 2003-07-14 Crystal forms of olanzapine and processes for their preparation
EA200500188A EA008055B1 (en) 2002-07-15 2003-07-14 The crystalline forms of olanzapine and methods for their preparation
AU2003256242A AU2003256242A1 (en) 2002-07-15 2003-07-14 Crystal forms of olanzapine and processes for their preparation
UAA200501303A UA83633C2 (en) 2002-07-15 2003-07-14 Process for the preparation of forms of olanzapine and solvates of olanzapine and use thereof for the preparation of anhydrous forms of olanzapine
HR20050039 HRP20050039B1 (en) 2002-07-15 2005-01-14 Crystal forms of olanzapine and processes for their preparation
NO20050720A NO20050720L (en) 2002-07-15 2005-02-10 The crystal form of olanzapine and process the feed for their preparation

Publications (2)

Publication Number Publication Date
WO2004006933A2 WO2004006933A2 (en) 2004-01-22
WO2004006933A3 true WO2004006933A3 (en) 2004-04-01

Family

ID=30113490

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SI2003/000024 WO2004006933A2 (en) 2002-07-15 2003-07-14 Crystal forms of olanzapine and processes for their preparation

Country Status (12)

Country Link
US (1) US7745429B2 (en)
EP (1) EP1551414B1 (en)
AU (1) AU2003256242A1 (en)
CA (1) CA2493370C (en)
EA (1) EA008055B1 (en)
HR (1) HRP20050039B1 (en)
NO (1) NO20050720L (en)
PL (1) PL217081B1 (en)
RS (1) RS53474B (en)
SI (2) SI21270A (en)
UA (1) UA83633C2 (en)
WO (1) WO2004006933A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL202856B1 (en) * 2002-12-20 2009-07-31 Adamed Spółka Z Ograniczoną Odpowiedzialnością Method of obtaining pharmaceutically pure polymorphic form of I olanzapine
EP1575962A1 (en) * 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
EP1711503A1 (en) * 2004-01-27 2006-10-18 Synthon B.V. Synthesis of olanzapine and intermediates thereof
DE602005027308D1 (en) 2004-01-27 2011-05-19 Synthon Bv Stable salt of olanzapin
EP1730153B1 (en) * 2004-03-08 2011-07-20 KRKA, tovarna zdravil, d.d., Novo mesto Isopropanol water solvate of olanzapine
ES2253091B1 (en) * 2004-07-27 2007-02-01 Inke, S.A. Mixed solvato of olanzapine, procedure for obtaining and procedure of obtaining the form i of olanzapine from the same.
GB0522473D0 (en) 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
EP0733635A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Crystal forms of a thieno(2,3-B)(1,5) benzodiazepine derivative and process for their preparation
EP0733634A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Process for preparing a thieno(2,3-B)(1,5) benzodiazepine derivative
WO2001047933A1 (en) * 1999-12-28 2001-07-05 Cipla Limited New polymorphic forms of olanzapine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU629879A3 (en) 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Method of obtaining thieno(1,5)-benzodiazepines or salts thereof
CR5278A (en) * 1995-03-24 1996-07-04 Lilly Co Eli oral formulation of 2-methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5776928A (en) * 1995-04-21 1998-07-07 Eli Lilly And Company Method for treating dyskinesias with olanzapine
US6506746B2 (en) * 1995-05-30 2003-01-14 Eli Lilly And Company Method for treating cognitive dysfunction
ZA9708515B (en) 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
ID21924A (en) 1996-09-23 1999-08-12 Lilly Co Eli Olanzapine dihydrate D
AU9583498A (en) * 1997-09-30 1999-04-23 Eli Lilly And Company Method for treating sexual dysfunction
WO2002018390A1 (en) 2000-08-31 2002-03-07 Dr. Reddy's Laboratories Ltd. Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
EP0733635A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Crystal forms of a thieno(2,3-B)(1,5) benzodiazepine derivative and process for their preparation
EP0733634A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Process for preparing a thieno(2,3-B)(1,5) benzodiazepine derivative
WO2001047933A1 (en) * 1999-12-28 2001-07-05 Cipla Limited New polymorphic forms of olanzapine

Also Published As

Publication number Publication date
PL373845A1 (en) 2005-09-19
US20060040920A1 (en) 2006-02-23
EA008055B1 (en) 2007-02-27
US7745429B2 (en) 2010-06-29
HRP20050039A2 (en) 2005-08-31
CA2493370A1 (en) 2004-01-22
SI1551414T1 (en) 2014-04-30
WO2004006933A2 (en) 2004-01-22
SI21270A (en) 2004-02-29
EP1551414B1 (en) 2013-11-27
RS53474B (en) 2014-12-31
HRP20050039B1 (en) 2014-10-10
CA2493370C (en) 2009-09-29
AU2003256242A1 (en) 2004-02-02
EA200500188A1 (en) 2005-06-30
EP1551414A2 (en) 2005-07-13
NO20050720L (en) 2005-02-10
UA83633C2 (en) 2008-08-11
RS20050023A (en) 2007-06-04
PL217081B1 (en) 2014-06-30

Similar Documents

Publication Publication Date Title
TWI370811B (en) Process for the preparation of ring compounds
BR0306886B1 (en) processes for the removal of acids from reaction mixtures by an auxiliary base, and for the preparation of phosphorus compounds from the respective reagents.
AU2002246125A1 (en) Process for preparing stabilized reaction mixtures which are partially dried, comprising at least one enzyme, reaction mixtures and kits containing said mixtures
HU0105338D0 (en) Process for hydrogenation of hydroforming mixture
WO2003029209A3 (en) Chemical compounds
DE60335965D1 (en) Method for producing final products from carbon substrates
AU2002247896A1 (en) Process for the preparation of a desired erythropoietin glyco-isoform profile
AU2003295941A1 (en) Process for olefin production
PL375298A1 (en) Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
EP1672077A4 (en) Process for producing succinic acid
AU2003226425A1 (en) Method of making transistors
AU2002255592A1 (en) Process aid for melt processable polymers
PT1633697E (en) Method for the production of substituted 3-aryl-butyl amine compounds
ZA200500611B (en) Method for the production of hydrogen-containing gaseous mixtures.
CA2509687A1 (en) Process for the production of 2'-branched nucleosides
WO2003059356A3 (en) Novel anti-infectives
AU2002349493A1 (en) Process for production of glutamic acid derivatives
AT461165T (en) Process for preparing butadiene from n-butane
GC0000409A (en) Process for the production of high quality base oils
WO2007053702A3 (en) Synthesis of four color 3'-o-allyl modified photocleavable fluorescent nucleotides and related methods
AU2002318145A1 (en) Process for making carbon foam induced by process depressurization
HK1056548A1 (en) Improved process for the production of (poly)isocyanates in the gas phase
MXPA02012795A (en) Carvedilol.
HK1068359A1 (en) Process for the production of polyol blends
AU2003251463A1 (en) Method for the production of low-emission polyurethane soft foams

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: P-2005/0023

Country of ref document: YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2493370

Country of ref document: CA

ENP Entry into the national phase in:

Ref document number: 2006040920

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10521646

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: P20050039A

Country of ref document: HR

Ref document number: 373845

Country of ref document: PL

WWE Wipo information: entry into national phase

Ref document number: 200500188

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2003764287

Country of ref document: EP

Ref document number: 184/CHENP/2005

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 2003764287

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10521646

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: JP

NENP Non-entry into the national phase in:

Ref country code: JP